Craig Fraser - Net Worth and Insider Trading
Craig Fraser Net Worth
The estimated net worth of Craig Fraser is at least $2,205 dollars as of 2025-01-12. Craig Fraser is the President and CEO of Windtree Therapeutics Inc and owns about 8,639 shares of Windtree Therapeutics Inc (WINT) stock worth over $2,205. Craig Fraser is also the Pres., US/Int. Comm. & Manuf. of Aegerion Pharmaceuticals Inc and owns about 0 shares of Aegerion Pharmaceuticals Inc (AEGR) stock worth over $0. Details can be seen in Craig Fraser's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Craig Fraser has not made any transactions after 2024-10-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Craig Fraser
Craig Fraser Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Craig Fraser owns 2 companies in total, including Windtree Therapeutics Inc (WINT) , and Aegerion Pharmaceuticals Inc (AEGR) .
Click here to see the complete history of Craig Fraser’s form 4 insider trades.
Insider Ownership Summary of Craig Fraser
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WINT | Windtree Therapeutics Inc | 2024-10-08 | director & Chief Executive Officer |
| AEGR | Aegerion Pharmaceuticals Inc | 2015-04-01 | Chief Operating Officer |
Craig Fraser Latest Holdings Summary
Craig Fraser currently owns a total of 2 stocks. Among these stocks, Craig Fraser owns 8,639 shares of Windtree Therapeutics Inc (WINT) as of October 8, 2024, with a value of $2,205 and a weighting of 100%. Craig Fraser also owns 0 shares of Aegerion Pharmaceuticals Inc (AEGR) as of April 30, 2014, with a value of $0 and a weighting of 0%.
Latest Holdings of Craig Fraser
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| WINT | Windtree Therapeutics Inc | 2024-10-08 | 8,639 | 0.26 | 2,205 |
| AEGR | Aegerion Pharmaceuticals Inc | 2014-04-30 | 0 | 1.97 | 0 |
Holding Weightings of Craig Fraser
Craig Fraser Form 4 Trading Tracker
According to the SEC Form 4 filings, Craig Fraser has made a total of 26 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 26 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 5,431 shares on October 8, 2024, which cost Craig Fraser around $4,942.
According to the SEC Form 4 filings, Craig Fraser has made a total of 0 transactions in Aegerion Pharmaceuticals Inc (AEGR) over the past 5 years. The most-recent trade in Aegerion Pharmaceuticals Inc is the sale of 2,250 shares on April 30, 2014, which brought Craig Fraser around $97,988.
Insider Trading History of Craig Fraser
- 1
Craig Fraser Trading Performance
GuruFocus tracks the stock performance after each of Craig Fraser's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig Fraser is -22.37%. GuruFocus also compares Craig Fraser's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig Fraser within 3 months outperforms 1 times out of 26 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Craig Fraser's insider trading performs compared to the benchmark.
Performance of Craig Fraser
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.05 | | | | | |
| Relative Return to S&P 500(%) | -6.78 | | | | | |
Craig Fraser Ownership Network
Ownership Network List of Craig Fraser
Ownership Network Relation of Craig Fraser
Craig Fraser Owned Company Details
What does Windtree Therapeutics Inc do?
Who are the key executives at Windtree Therapeutics Inc?
Craig Fraser is the director & Chief Executive Officer of Windtree Therapeutics Inc. Other key executives at Windtree Therapeutics Inc include VP & Controller & & CAO Jamie Mcandrew , SVP & CFO John P. Hamill , and 10 percent owner Center Laboratories, Inc. .
Windtree Therapeutics Inc (WINT) Insider Trades Summary
Over the past 18 months, Craig Fraser made 3 insider transaction in Windtree Therapeutics Inc (WINT) with a net purchase of 10,431.
In summary, during the past 3 months, insiders sold 0 shares of Windtree Therapeutics Inc (WINT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Windtree Therapeutics Inc (WINT) were sold and 5,709 shares were bought by its insiders, resulting in a net purchase of 5,709 shares.
Windtree Therapeutics Inc (WINT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Windtree Therapeutics Inc Insider Transactions
Craig Fraser Mailing Address
Above is the net worth, insider trading, and ownership report for Craig Fraser. You might contact Craig Fraser via mailing address: Aegerion Pharmaceuticals, Inc., 101 Main Street, Suite 1850, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
